Skip to main content
Top
Published in: BMC Hematology 1/2019

Open Access 01-12-2019 | Chronic Lymphocytic Leukemia | Research article

Patterns of bone marrow aspiration confirmed hematological malignancies in Eritrean National Health Laboratory

Authors: Natnael Belai, Amon Solomon Ghebrenegus, Amin Ata Alamin, Ghirmay Embaye, Amanuel Kidane Andegiorgish

Published in: BMC Hematology | Issue 1/2019

Login to get access

Abstract

Background

Even though the incidences of hematologic malignancies have received considerable attentions globally, there is paucity of information on patterns of hematologic malignancy in Eritrea. The study was conducted to determine the distribution of various hematologic malignancies among patients who have received bone marrow examination, in the Eritrean National Health Laboratory.

Methods

A retrospective descriptive study design was used to determine the patterns of Hematologic malignancies diagnosed at the Eritrean National Health Laboratory from October 2015 to July 2017.

Results

Out of 207 patients who did bone marrow aspiration 52 patients were hematologic malignancy cases. The male to female ratio was 1:1. The age of the patients ranged from 2 to 80 years. Of the 52 patients 19, were less than 20 years of age and the remaining 33 were 20 years and above. Acute leukemia was the most common hematologic malignancy in the study area. It affected 18 of the cases followed by chronic myelogenous leukemia, chronic lymphocytic leukemia, myelodysplastic syndromes, multiple myeloma, and myeloprofilerative neoplasms. The presenting signs and symptoms in their decreasing frequency were generalized body weakness/fatigue, splenomegaly, fever, anemia, and lymphadenopathy. More than two-third of the patients had total leukocyte count greater than 10,000/μl.

Conclusion

This study shows that hematologic malignancies are not uncommon in Eritrea.
Literature
1.
go back to reference American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
2.
go back to reference American Cancer Society. Cancer in Africa. Atlanta: American Cancer Society; 2011. American Cancer Society. Cancer in Africa. Atlanta: American Cancer Society; 2011.
3.
go back to reference Adom H, Tesfamichael D, Weldu H, Hailemichael M, Eman D, Mehari T, Semere G, Fadlelmola F. Trends in the incidence of Cancer in Eritrean hospitals and Eritrean National Health Laboratory 2000-2010. UKJPB. 2016;4(5):47–55. Adom H, Tesfamichael D, Weldu H, Hailemichael M, Eman D, Mehari T, Semere G, Fadlelmola F. Trends in the incidence of Cancer in Eritrean hospitals and Eritrean National Health Laboratory 2000-2010. UKJPB. 2016;4(5):47–55.
4.
go back to reference Flowers CR, Glover R, Lonial S, Brawley OW. Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer. 2007;31(3):182–201.CrossRef Flowers CR, Glover R, Lonial S, Brawley OW. Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer. 2007;31(3):182–201.CrossRef
5.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136(5):E359–86.CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136(5):E359–86.CrossRef
6.
go back to reference Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol. 2007;18(Suppl 1):i3–8.CrossRef Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol. 2007;18(Suppl 1):i3–8.CrossRef
7.
go back to reference Lichtman MA. Battling the hematological malignancies: the 200 years’ war. Oncologist. 2008;13(2):126–38.CrossRef Lichtman MA. Battling the hematological malignancies: the 200 years’ war. Oncologist. 2008;13(2):126–38.CrossRef
8.
go back to reference Hamid GA. The pattern of hematological malignancies at Al-Gamhouria teaching hospital, Aden, Yemen, from 2008 to 2010. Turk J Hematol. 2012;29:342–7.CrossRef Hamid GA. The pattern of hematological malignancies at Al-Gamhouria teaching hospital, Aden, Yemen, from 2008 to 2010. Turk J Hematol. 2012;29:342–7.CrossRef
9.
go back to reference Smith A, Howell D, Patmore R, Jac A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological malignancy research network. Br J Cancer. 2011;105:1684–92.CrossRef Smith A, Howell D, Patmore R, Jac A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological malignancy research network. Br J Cancer. 2011;105:1684–92.CrossRef
10.
go back to reference Errahhali ME, Errahhali ME, Boulouiz R, Ouarzane M, Bellaoui M. Distribution and features of haematological malignancies in eastern Morocco: a retrospective multicenter study over 5 years. BMC Cancer. 2016;16:159.CrossRef Errahhali ME, Errahhali ME, Boulouiz R, Ouarzane M, Bellaoui M. Distribution and features of haematological malignancies in eastern Morocco: a retrospective multicenter study over 5 years. BMC Cancer. 2016;16:159.CrossRef
11.
go back to reference Hossain MS, Iqbal MS, Khan MA, Rabbani MG, Khatun H. Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer. 2014;14:438.CrossRef Hossain MS, Iqbal MS, Khan MA, Rabbani MG, Khatun H. Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer. 2014;14:438.CrossRef
12.
go back to reference Babatunde A, Amiwero C, Olatunji P, Durotoye I. Pattern of Haematological Malignancies in Ilorin, Nigeria: A Ten Year Review. Internet J Hematol. 2008;5(2)1–7. Babatunde A, Amiwero C, Olatunji P, Durotoye I. Pattern of Haematological Malignancies in Ilorin, Nigeria: A Ten Year Review. Internet J Hematol. 2008;5(2)1–7.
13.
go back to reference Curado MP, Edwards B, Shin HR, et al., editors. Cancer Incidence in Five Continents, Vol. 9. Lyon: International Agency for Research on Cancer; 2007. p. 101. Curado MP, Edwards B, Shin HR, et al., editors. Cancer Incidence in Five Continents, Vol. 9. Lyon: International Agency for Research on Cancer; 2007. p. 101.
14.
go back to reference Prajapati Z, Kokani MJ, Gonsai RN. Clinicoepidemiological profile of hematological malignancies in pediatric age group in Ahmedabad. Asian J Oncol. 2017;3:54–8.CrossRef Prajapati Z, Kokani MJ, Gonsai RN. Clinicoepidemiological profile of hematological malignancies in pediatric age group in Ahmedabad. Asian J Oncol. 2017;3:54–8.CrossRef
15.
go back to reference Weldetsadik AT. Clinical characteristics of patients with hematological malignancies at Gondar university hospital. North West Ethiopia Ethiop Med J. 2013;51(1):25–31.PubMed Weldetsadik AT. Clinical characteristics of patients with hematological malignancies at Gondar university hospital. North West Ethiopia Ethiop Med J. 2013;51(1):25–31.PubMed
16.
go back to reference Das KV, Aboobacker CM, Mathew O. Clinical presentation of leukemias in children in South Kerala. Indian Pediatr. 1974;11:431–8.PubMed Das KV, Aboobacker CM, Mathew O. Clinical presentation of leukemias in children in South Kerala. Indian Pediatr. 1974;11:431–8.PubMed
17.
go back to reference Siddaiahgari SR, Awaghad MA, Latha MS. Clinical, immunophenotype and cytogenetic profi le of acute lymphoblastic leukemia in children at tertiary health care Centre in India. Muller J Med Sci Res. 2015;6:112–8.CrossRef Siddaiahgari SR, Awaghad MA, Latha MS. Clinical, immunophenotype and cytogenetic profi le of acute lymphoblastic leukemia in children at tertiary health care Centre in India. Muller J Med Sci Res. 2015;6:112–8.CrossRef
18.
go back to reference Herzog CM, Dey S, Hablas A, Khaled HM, Seifeldin IA, Ramadan M, El-Hamzawy H, Wilson ML, Soliman AS. Geographic distribution of hematopoietic cancers in the Nile delta of Egypt. Ann Oncol. 2012;23:2748–55.CrossRef Herzog CM, Dey S, Hablas A, Khaled HM, Seifeldin IA, Ramadan M, El-Hamzawy H, Wilson ML, Soliman AS. Geographic distribution of hematopoietic cancers in the Nile delta of Egypt. Ann Oncol. 2012;23:2748–55.CrossRef
19.
go back to reference Mashhadi MA, Zakeri Z, Abdollahinejad MJ. Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry. Shiraz E-Medical Journal. 2010;11(3)145–55. Mashhadi MA, Zakeri Z, Abdollahinejad MJ. Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry. Shiraz E-Medical Journal. 2010;11(3)145–55.
Metadata
Title
Patterns of bone marrow aspiration confirmed hematological malignancies in Eritrean National Health Laboratory
Authors
Natnael Belai
Amon Solomon Ghebrenegus
Amin Ata Alamin
Ghirmay Embaye
Amanuel Kidane Andegiorgish
Publication date
01-12-2019

Other articles of this Issue 1/2019

BMC Hematology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.